NBIX
$143.18+1.76%
as of close, Oct 2, 2026
☾ AH $143.18 +1.76%
Neurocrine Biosciences Inc.Stock · Health CareNasdaq Composite 0.03%Russell 1000 0.02%US Stock Market 0.02%Russell 3000 0.02%MSCI World 0.02%MSCI ACWI 0.02%
Neurocrine Biosciences Inc. returns by year
As of market close, Oct 2, 2026
Neurocrine Biosciences Inc. returns by year (1997–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $141.83 | $143.18 | 0.0% | +1.0% | |
| 2025 | $136.50 | $141.83 | 0.0% | +3.9% | |
| 2024 | $131.76 | $136.50 | 0.0% | +3.6% | |
| 2023 | $119.44 | $131.76 | 0.0% | +10.3% | |
| 2022 | $85.17 | $119.44 | 0.0% | +40.2% | |
| 2021 | $95.85 | $85.17 | 0.0% | -11.1% | |
| 2020 | $107.49 | $95.85 | 0.0% | -10.8% | |
| 2019 | $71.41 | $107.49 | 0.0% | +50.5% | |
| 2018 | $77.59 | $71.41 | 0.0% | -8.0% | |
| 2017 | $38.70 | $77.59 | 0.0% | +100.5% | |
| 2016 | $56.57 | $38.70 | 0.0% | -31.6% | |
| 2015 | $22.34 | $56.57 | 0.0% | +153.2% | |
| 2014 | $9.34 | $22.34 | 0.0% | +139.2% | |
| 2013 | $7.48 | $9.34 | 0.0% | +24.9% | |
| 2012 | $8.50 | $7.48 | 0.0% | -12.0% | |
| 2011 | $7.64 | $8.50 | 0.0% | +11.3% | |
| 2010 | $2.72 | $7.64 | 0.0% | +180.9% | |
| 2009 | $3.20 | $2.72 | 0.0% | -15.0% | |
| 2008 | $4.54 | $3.20 | 0.0% | -29.5% | |
| 2007 | $10.42 | $4.54 | 0.0% | -56.4% | |
| 2006 | $62.73 | $10.42 | 0.0% | -83.4% | |
| 2005 | $49.30 | $62.73 | 0.0% | +27.2% | |
| 2004 | $54.54 | $49.30 | 0.0% | -9.6% | |
| 2003 | $45.66 | $54.54 | 0.0% | +19.4% | |
| 2002 | $51.31 | $45.66 | 0.0% | -11.0% | |
| 2001 | $33.13 | $51.31 | 0.0% | +54.9% | |
| 2000 | $24.75 | $33.13 | 0.0% | +33.8% | |
| 1999 | $6.88 | $24.75 | 0.0% | +260.0% | |
| 1998 | $7.88 | $6.88 | 0.0% | -12.7% | |
| 1997 | $10.00 | $7.88 | 0.0% | -21.3% |
- Annualized
- +8.8%
- 1997–2026
- Average year
- +27.6%
- 29 full years
- Best year
- +260.0%
- 1999
- Worst year
- -83.4%
- 2006
- Positive years
- 16/29
- 55% up
Annualized (CAGR)
+8.8%
1997–2026
Average year
+27.6%
29 full years
Best year
+260.0%
1999
Worst year
-83.4%
2006
Positive years
16/29
55% up
Total return by period#
Annual
-200%-100%0%100%200%
1997-21%'97
1998-13%
1999+260%
2000+34%'00
2001+55%
2002-11%
2003+19%'03
2004-9.6%
2005+27%
2006-83%'06
2007-56%
2008-30%
2009-15%'09
2010+181%
2011+11%
2012-12%'12
2013+25%
2014+139%
2015+153%'15
2016-32%
2017+100%
2018-8.0%'18
2019+51%
2020-11%
2021-11%'21
2022+40%
2023+10%
2024+3.6%'24
2025+3.9%
2026+0.95%
Methodology#
Total returns, dividends reinvested, measured on NBIX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Neurocrine Biosciences Inc.'s average annual return?
- Since 1997, Neurocrine Biosciences Inc. (NBIX) has returned about 8.8% a year (the compound annual growth rate) and an average calendar-year return of 27.6%.
- What were Neurocrine Biosciences Inc.'s best and worst years?
- Over 1997–2026, the best year was 1999 (+260.0%) and the worst was 2006 (-83.4%).
- How often is Neurocrine Biosciences Inc. up in a year?
- 16 of the 29 full years since 1997 were positive — about 55% of the time.
More on Neurocrine Biosciences Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100